SCHEMBL21177932

SCHEMBL21177932

CCC(C)(C)OOCCCOC(=O)O

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32
HCAR2 Q8TDS4 2/20 0.31
ATM Q13315 1/20 0.31
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30595883 0.96 HCAR2 (0.33) ALDH1A1HCAR2ATMTSHR
SCHEMBL21177931 0.89 ALDH1A1 (0.36) ALDH1A1ATMTSHR
SCHEMBL30457392 0.89 TSHR (0.32) ALDH1A1TSHR
SCHEMBL2489893 0.86 ALDH1A1 (0.34) ALDH1A1HCAR2ATMTSHR
SCHEMBL31164259 0.84 ALDH1A1 (0.37) ALDH1A1HCAR2ATMTSHR
SCHEMBL31164260 0.84
SCHEMBL2119040 0.82 ALDH1A1 (0.31) ALDH1A1
SCHEMBL986351 0.82 NAAA (0.35) ALDH1A1HCAR2ATMTSHR
SCHEMBL7801141 0.82 TSHR (0.41) ALDH1A1TSHR
SCHEMBL31055388 0.81 NAAA (0.38) ALDH1A1HCAR2ATMTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4692177-A1 RESIN POWDER AND METHOD FOR PRODUCING SAME Kaneka Corporation (JP) 2026-02-11 EP disclosed
US-20250388748-A1 THERMOPLASTIC RESIN COMPOSITION KANEKA CORPORATION (JP) 2025-12-25 US disclosed
EP-4610313-A1 THERMOPLASTIC RESIN COMPOSITION Kaneka Corporation (JP) 2025-09-03 EP disclosed
US-20250250435-A1 THERMOPLASTIC RESIN COMPOSITION KANEKA CORPORATION (JP) 2025-08-07 US disclosed
US-20250243321-A1 METHOD FOR PRODUCING MODIFIED ALIPHATIC OR ALIPHATIC-AROMATIC THERMOPLASTIC POLYESTER RESIN KANEKA CORPORATION (JP) 2025-07-31 US disclosed
US-20250230273-A1 CROSSLINKED RESIN PARTICLES AND METHOD FOR PRODUCING THE SAME KANEKA CORPORATION (JP) 2025-07-17 US disclosed
US-20250215215-A1 THERMOPLASTIC RESIN COMPOSITION KANEKA CORPORATION (JP) 2025-07-03 US disclosed
US-20250066538-A1 MODIFIED ALIPHATIC POLYESTER RESIN AND COMPOSITION OR MOLDED ARTICLE THEREOF KANEKA CORPORATION (JP) 2025-02-27 US disclosed
EP-4506395-A1 CROSSLINKED RESIN PARTICLES AND METHOD FOR PRODUCING SAME Kaneka Corporation (JP) 2025-02-12 EP disclosed
EP-4502082-A1 THERMOPLASTIC RESIN COMPOSITION Kaneka Corporation (JP) 2025-02-05 EP disclosed
EP-4502081-A1 THERMOPLASTIC RESIN COMPOSITION Kaneka Corporation (JP) 2025-02-05 EP disclosed
EP-4467589-A1 MODIFIED ALIPHATIC POLYESTER-BASED RESIN AND COMPOSITION OR MOLDED BODY THEREOF Kaneka Corporation (JP) 2024-11-27 EP disclosed
EP-4467590-A1 METHOD FOR MANUFACTURING MODIFIED ALIPHATIC OR ALIPHATIC AROMATIC THERMOPLASTIC POLYESTER RESIN Kaneka Corporation (JP) 2024-11-27 EP disclosed
WO-2019142803-A1 MATRIX RESIN, INTERMEDIATE MATERIAL, AND MOLDED ARTICLE 三菱ケミカル株式会社 2019-07-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250388748-A1 THERMOPLASTIC RESIN COMPOSITION HSPA4L, HSP90AA1, HACD3 ALDH1A1 268/4885HCAR2 339/4885ATM 2974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.